Drug Approval | July 05, 2022
Novavax aims COVID vaccine on Omicron in Q4
The vaccine is under FDA review
The vaccine is under FDA review
_256_384.jpg){kind=logo}
Meets the growing need for US-based API solubility and bioavailability enhancement services
Strengthens investment in channels of the future to expand patient reach
Both vaccine candidates demonstrated a favorable safety and tolerability profile similar to the Pfizer-BioNTech COVID-19 Vaccine
The company has launched indigenously produced Dual Chamber Bags of global standards in India at a pocket-friendly price
The new Oncology CRO will aim to drive faster execution and higher quality trial outcomes for Oncology sponsors.
Govt. has set a target to increase the number of JanAushadhi Kendras to 10,000 by March 2024
Trial will assess safety and antibody responses of NVX-CoV2515 to the Omicron variant of COVID-19
Bempedoic acid helps lower cardiovascular risk in high or very high-risk atherosclerotic cardiovascular disease (ASCVD) patients as an add-on therapy to maximally tolerated statin and/or ezetimibe
The company has posted net profit of Rs.884.08 crores for the Financial Year ended March 31, 2022.
Subscribe To Our Newsletter & Stay Updated
